The role of molecular chaperonins in warm ischemia and reperfusion injury in the steatotic liver: A proteomic study

BMC Biochemistry

Volumn 13, Issue 1, 2012, Pages

  Tiriveedhi, Venkataswarup ^a,c   Conzen, Kendra D ^a   Liaw Conlin, Jane ^a   Upadhya, Gundumi ^a   Malone, James ^a   Townsend, R Reid ^a   Kerns, Robnet ^a   Jia, Jianluo ^a   Csontos, Krista ^a   Ramachandran, Sabarinathan ^a   Mohanakumar, Thallachallour ^a   Anderson, Christopher D ^b   Chapman, William C ^a,c  

^a WASHINGTON UNIVERSITY   (United States)

^b UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

^c WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Chaperonins; Endoplasmic reticulum (ER) stress; Ischemia repurfusion injury; Liver transplantation; Mass spectrometry; Two dimensional gel electrophoresis

Indexed keywords

CALCIUM BINDING PROTEIN; CALCIUM BINDING PROTEIN 1; CALRETICULIN; CHAPERONIN; HEAT SHOCK PROTEIN; HEAT SHOCK PROTEIN 60; HEAT SHOCK PROTEIN 90; HYPOXIA UPREGULATED PROTEIN 1; LIVER PROTEIN; PROTEIN DISULFIDE ISOMERASE; PROTEIN DISULFIDE ISOMERASE 3; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL STRUCTURE; CONTROLLED STUDY; ENDOPLASMIC RETICULUM STRESS; FATTY LIVER; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; ISCHEMIA; MASS SPECTROMETRY; METABOLISM; NONHUMAN; OXIDATIVE STRESS; PROTEIN ANALYSIS; PROTEIN TARGETING; PROTEOMICS; RAT; REPERFUSION INJURY; TWO DIMENSIONAL DIFFERENCE GEL ELECTROPHORESIS; UPREGULATION;

ANIMALS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DATABASES, PROTEIN; DOWN-REGULATION; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; ENDOPLASMIC RETICULUM STRESS; FATTY LIVER; MALE; MASS SPECTROMETRY; MOLECULAR CHAPERONES; PROTEOME; PROTEOMICS; RATS; RATS, ZUCKER; REPERFUSION INJURY; UP-REGULATION; WARM ISCHEMIA;

ANIMALIA; RATTUS;

EID: 84865843675     PISSN: None     EISSN: 14712091     Source Type: Journal    
DOI: 10.1186/1471-2091-13-17     Document Type: Article

References (41)

1. U.S. Scientific Registry of Transplant Recipients, 2008 Annual Report of the US organ pocurement and Transplantation network and the Scietific Registry of Transplant Recipients: Transplant data 1998-2007 U.S. Department of Health and Human Resources, Division of Transplantation, Rockville 2008
2. The use of donor fatty liver for liver transplantation: a challenge or a quagmire? Trevisani F, Colantoni A, Caraceni P, Van Thiel DH, J Hepatol 1996 24 1 114 121 8834034 (Pubitemid 26035984)
3. Hepatic steatosis in liver transplant donors: rare phenomenon or common feature of donor population? Halon A, Patrzalek D, Rabczynski J, Transplant Proc 2006 38 1 193 195 10.1016/j.transproceed.2005.11.088 16504700
4. Primary nonfunction of hepatic allografts with preexisting fatty infiltration. Todo S, Demetris AJ, Makowka L, Teperman L, Podesta L, Shaver T, Tzakis A, Starzl TE, Transplantation 1989 47 5 903 905 10.1097/00007890- 198905000-00034 2655230 (Pubitemid 19139140)
5. Fatty liver in liver transplantation and surgery. Selzner M, Clavien PA, Semin Liver Dis 2001 21 1 105 113 10.1055/s-2001-12933 11296690 (Pubitemid 32240490)
6. Risk factors for primary dysfunction after liver transplantation-a multivariate analysis. Ploeg RJ, D'Alessandro AM, Knechtle SJ, Stegall MD, Pirsch JD, Hoffmann RM, Sasaki T, Sollinger HW, Belzer FO, Kalayoglu M, Transplantation 1993 55 4 807 813 10.1097/00007890-199304000-00024 8475556 (Pubitemid 23122053)
7. Selecting the donor liver: risk factors for poor function after orthotopic liver transplantation. Strasberg SM, Howard TK, Molmenti EP, Hertl M, Hepatology 1994 20 4 Pt 1 829 838 7927223 (Pubitemid 24296488)
8. The role of proteomics in clinical cardiovascular biomarker discovery. Edwards AV, White MY, Cordwell SJ, Mol Cell Proteomics 2008 7 10 1824 1837 10.1074/mcp.R800007-MCP200 18667414
9. Getting to the heart of proteomics. Ping P, N Engl J Med 2009 360 5 532 534 10.1056/NEJMcibr0808487 19179323
10. Redox proteomics and immunohistology to study molecular events during ischemia-reperfusion in human liver. Avellini C, Baccarani U, Trevisan G, Cesaratto L, Vascotto C, D'Aurizio F, Pandolfi M, Adani GL, Tell G, Transplant Proc 2007 39 6 1755 1760 10.1016/j.transproceed.2007.05.082 17692604 (Pubitemid 47198841)
11. Proteomic analysis of ischemia-reperfusion injury upon human liver transplantation reveals the protective role of IQGAP1. Emadali A, Muscatelli-Groux B, Delom F, Jenna S, Boismenu D, Sacks DB, Metrakos PP, Chevet E, Mol Cell Proteomics 2006 5 7 1300 1313 10.1074/mcp.M500393-MCP200 16622255 (Pubitemid 44103400)
12. Peroxiredoxin-6 protects against mitochondrial dysfunction and liver injury during ischemia-reperfusion in mice. Eismann T, Huber N, Shin T, Kuboki S, Galloway E, Wyder M, Edwards MJ, Greis KD, Shertzer HG, Fisher AB, et al. Am J Physiol Gastrointest Liver Physiol 2009 296 2 266 274 19033532
13. Warm ischemia-induced alterations in oxidative and inflammatory proteins in hepatic Kupffer cells in rats. Hirsch J, Hansen KC, Choi S, Noh J, Hirose R, Roberts JP, Matthay MA, Burlingame AL, Maher JJ, Niemann CU, Mol Cell Proteomics 2006 5 6 979 986 10.1074/mcp.M500320-MCP200 16500929 (Pubitemid 43985923)
14. Identification and preliminary validation of novel biomarkers of acute hepatic ischaemia/reperfusion injury using dual-platform proteomic/degradomic approaches. Svetlov SI, Xiang Y, Oli MW, Foley DP, Huang G, Hayes RL, Ottens AK, Wang KK, Biomarkers 2006 11 4 355 369 10.1080/13547500600775110 16908442
15. Proteomic analysis of hepatic ischemia/reperfusion injury and ischemic preconditioning in mice revealed the protective role of ATP5beta. Xu C, Zhang X, Yu C, Lu G, Chen S, Xu L, Ding W, Shi Q, Li Y, Proteomics 2009 9 2 409 419 10.1002/pmic.200800393 19142948
16. Liver proteome analysis in a rodent model of alcoholic steatosis. Newton BW, Russell WK, Russell DH, Ramaiah SK, Jayaraman A, J Proteome Res 2009 8 4 1663 1671 10.1021/pr800905w 19714808
17. Steatosis-induced proteomic changes in liver mitochondria evidenced by two-dimensional differential in-gel electrophoresis. Douette P, Navet R, Gerkens P, De Pauw E, Leprince P, Sluse-Goffart C, Sluse FE, J Proteome Res 2005 4 6 2024 2031 10.1021/pr050187z 16335947 (Pubitemid 41814268)
18. Role of the mitochondrial permeability transition in myocardial disease. Weiss JN, Korge P, Honda HM, Ping P, Circ Res 2003 93 4 292 301 10.1161/01.RES.0000087542.26971.D4 12933700 (Pubitemid 37048241)
19. Proteomic analysis of liver tissues subjected to early ischemia/reperfusion injury during human orthotopic liver transplantation. Vascotto C, Cesaratto L, D'Ambrosio C, Scaloni A, Avellini C, Paron I, Baccarani U, Adani GL, Tiribelli C, Quadrifoglio F, et al. Proteomics 2006 6 11 3455 3465 10.1002/pmic.200500770 16622838 (Pubitemid 43886161)
20. A proteomic approach for the discovery of protease substrates. Bredemeyer AJ, Lewis RM, Malone JP, Davis AE, Gross J, Townsend RR, Ley TJ, Proc Natl Acad Sci U S A 2004 101 32 11785 11790 10.1073/pnas.0402353101 15280543 (Pubitemid 39095372)
21. The current state of two-dimensional electrophoresis with immobilized pH gradients. Gorg A, Obermaier C, Boguth G, Harder A, Scheibe B, Wildgruber R, Weiss W, Electrophoresis 2000 21 6 1037 1053 10.1002/(SICI)1522-2683(20000401) 21:6<1037::AID-ELPS1037>3.0.CO;2-V 10786879 (Pubitemid 30230771)
22. A novel experimental design for comparative two-dimensional gel analysis: two-dimensional difference gel electrophoresis incorporating a pooled internal standard. Alban A, David SO, Bjorkesten L, Andersson C, Sloge E, Lewis S, Currie I, Proteomics 2003 3 1 36 44 10.1002/pmic.200390006 12548632 (Pubitemid 36151066)
23. Difference gel electrophoresis: a single gel method for detecting changes in protein extracts. Unlu M, Morgan ME, Minden JS, Electrophoresis 1997 18 11 2071 2077 10.1002/elps.1150181133 9420172 (Pubitemid 27501267)
24. Determining a significant change in protein expression with DeCyder during a pair-wise comparison using two-dimensional difference gel electrophoresis. Karp NA, Kreil DP, Lilley KS, Proteomics 2004 4 5 1421 1432 10.1002/pmic.200300681 15188411 (Pubitemid 38648032)
25. Fast-response proteomics by accelerated in-gel digestion of proteins. Havlis J, Thomas H, Sebela M, Shevchenko A, Anal Chem 2003 75 6 1300 1306 10.1021/ac026136s 12659189 (Pubitemid 36397161)
26. Accurate mass-driven analysis for the characterization of protein phosphorylation. Study of the human Chk2 protein kinase. King JB, Gross J, Lovly CM, Rohrs H, Piwnica-Worms H, Townsend RR, Anal Chem 2006 78 7 2171 2181 10.1021/ac051520l 16579595
27. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Shannon P, Markiel A, Ozier O, Baliga NS, Wang JT, Ramage D, Amin N, Schwikowski B, Ideker T, Genome Res 2003 13 11 2498 2504 10.1101/gr.1239303 14597658 (Pubitemid 37428274)
28. Correlation between protein and mRNA abundance in yeast. Gygi SP, Rochon Y, Franza BR, Aebersold R, Mol Cell Biol 1999 19 3 1720 1730 10022859 (Pubitemid 29098230)
29. The N-end rule: functions, mysteries, uses. Varshavsky A, Proc Natl Acad Sci U S A 1996 93 22 12142 12149 10.1073/pnas.93.22.12142 8901547 (Pubitemid 26367109)
30. Major challenges limiting liver transplantation in the United States. Wertheim JA, Petrowsky H, Saab S, Kupiec-Weglinski JW, Busuttil RW, Am J Transplant 2011 11 9 1773 1784 10.1111/j.1600-6143.2011.03587.x 21672146
31. Chaperone-mediated protein folding. Fink AL, Physiol Rev 1999 79 2 425 449 10221986 (Pubitemid 29210927)
32. Mediators of endoplasmic reticulum stress-induced apoptosis. Szegezdi E, Logue SE, Gorman AM, Samali A, EMBO Rep 2006 7 9 880 885 10.1038/sj.embor. 7400779 16953201 (Pubitemid 44523966)
33. The known unknowns of antigen processing and presentation. Vyas JM, Van der Veen AG, Ploegh HL, Nat Rev Immunol 2008 8 8 607 618 10.1038/nri2368 18641646
34. Misfolded major histocompatibility complex class I heavy chains are translocated into the cytoplasm and degraded by the proteasome. Hughes EA, Hammond C, Cresswell P, Proc Natl Acad Sci U S A 1997 94 5 1896 1901 10.1073/pnas.94.5.1896 9050876 (Pubitemid 27113933)
35. ER chaperones in mammalian development and human diseases. Ni M, Lee AS, FEBS Lett 2007 581 19 3641 3651 10.1016/j.febslet.2007.04.045 17481612 (Pubitemid 47082516)
36. PTEN activity is modulated during ischemia and reperfusion: involvement in the induction and decay of preconditioning. Cai Z, Semenza GL, Circ Res 2005 97 12 1351 1359 10.1161/01.RES.0000195656.52760.30 16284183
37. Endoplasmic reticulum stress inhibition protects steatotic and non-steatotic livers in partial hepatectomy under ischemia-reperfusion. Ben Mosbah I, Alfany-Fernandez I, Martel C, Zaouali MA, Bintanel-Morcillo M, Rimola A, Rodes J, Brenner C, Rosello-Catafau J, Peralta C, Cell Death Dis 2010 1 52 10.1038/cddis.2010.29 21364657
38. Endoplasmic reticulum stress is a mediator of posttransplant injury in severely steatotic liver allografts. Anderson CD, Upadhya G, Conzen KD, Jia J, Brunt EM, Tiriveedhi V, Xie Y, Ramachandran S, Mohanakumar T, Davidson NO, et al. Liver Transpl 2011 17 2 189 200 10.1002/lt.22220 21280192
39. Myocardial injury leads to a release of heat shock protein (hsp) 60 and a suppression of the anti-hsp65 immune response. Schett G, Metzler B, Kleindienst R, Amberger A, Recheis H, Xu Q, Wick G, Cardiovasc Res 1999 42 3 685 695 10.1016/S0008-6363(99)00012-7 10533609 (Pubitemid 29298138)
40. Malaria heat shock proteins: drug targets that chaperone other drug targets. Pesce ER, Cockburn IL, Goble JL, Stephens LL, Blatch GL, Infect Disord Drug Targets 2010 10 3 147 157 20334623
41. Evaluation of two-dimensional gel electrophoresis-based proteome analysis technology. Gygi SP, Corthals GL, Zhang Y, Rochon Y, Aebersold R, Proc Natl Acad Sci U S A 2000 97 17 9390 9395 10.1073/pnas.160270797 10920198 (Pubitemid 30650785)